Lara Garcia-Arias
Burgos, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Time trends in strategies for postoperative Crohn's disease management and long-term surgical recurrence: ENEIDA registry data.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 05, 2026
Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry.
Journal: Journal of Crohn's & colitis
Published: August 22, 2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.
Journal: Pharmaceutics
Published: March 25, 2024
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.
Journal: Journal of Crohn's & colitis
Published: July 31, 2023
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Journal: Therapeutic advances in gastroenterology
Published: June 19, 2023
Low risk of new dysplastic lesions in an inflammatory bowel disease population study with dye chromoendoscopy.
Journal: Endoscopy international open
Published: August 23, 2022
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry.
Journal: Journal of Crohn's & colitis
Published: August 01, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Journal: Inflammatory bowel diseases
Published: September 10, 2021
Efficacy of lanreotide in patients with gastrointestinal angiodysplasia refractory to octreotide therapy
Journal: Gastroenterologia y hepatologia
Published: November 13, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026